About Kevin Heyries
Form D filings for Inceptive Nucleics in 2023 list Kevin Heyries as executive officer.
Kevin Heyries first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Kevin Heyries in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kevin Heyries works with at each company, as listed on that company's latest Form D.
Inceptive Nucleics, Inc. · Form D, Sep 20, 2023
JU
Jakob Uszkoreit
Chief Executive Officer and director
VP
Vijay Pande
Director
DA
Diana Ajuria
Executive officer
DK
Do Soon Kim
Executive officer